Vet Med - Czech, 2019, 64(2):67-77 | DOI: 10.17221/123/2018-VETMED

Post-antibiotic effect of marbofloxacin, enrofloxacin and amoxicillin against selected respiratory pathogens of pigsOriginal Paper

Katerina Nedbalcova*,1, Monika Zouharova1, Daniel Sperling2
1 Veterinary Research Institute, Brno, Czech Republic
2 Ceva Santé Animale S.A., Libourne, France

The post-antibiotic effect is defined as the period of bacterial growth suppression that persists after a limited exposure of organisms to antimicrobials and knowledge of its duration is important in establishing and optimising current dosing schedules for the treatment of bacterial infections. The post-antibiotic effect of marbofloxacin, enrofloxacin and amoxicillin were evaluated in vitro for Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida strains which originated from clinical samples of diseased pigs and were confirmed as susceptible to all tested antimicrobials based on determination of minimal inhibitory concentrations. The post-antibiotic effect for individual antimicrobials was monitored at five and ten times minimum inhibitory concentrations for one and two hours. The duration of the post-antibiotic effect for tested antimicrobials was found to exhibit the following order for all tested pathogens: marbofloxacin > enrofloxacin > amoxicillin. The longest duration of post-antibiotic effect of all tested antimicrobials was found in A. pleuropneumoniae and the shortest post-antibiotic effect duration was detected in P. multocida. No statistical differences in post-antibiotic effect duration were found within marbofloxacin and enrofloxacin in A. pleuropneumoniae and H. parasuis strains. In P. multocida strains there was a statistically significant difference (P = 0.0189). On the other hand, the differences between amoxicillin and marbofloxacin or enrofloxacin were statistically significant in all cases (P-values ranged between 0.0058 and 0.008). The prolonged post-antibiotic effect of fluoroquinolones and amoxicillin on important Gram-negative swine pathogens was confirmed. The results can be used to clarify the effect and mechanism of action of antimicrobial drugs in veterinary medicine.

Keywords: antimicrobials; antimicrobial treatment; antimicrobial susceptibility testing; infection of swine; PAE duration

Published: February 28, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nedbalcova K, Zouharova M, Sperling D. Post-antibiotic effect of marbofloxacin, enrofloxacin and amoxicillin against selected respiratory pathogens of pigs. Vet Med - Czech. 2019;64(2):67-77. doi: 10.17221/123/2018-VETMED.
Download citation

References

  1. Aarestrup F, Seyfarth A, Angen O (2004): Antimicrobial susceptibility of Haemophilus parasuis and Histophilus somni from pigs and cattle in Denmark. Veterinary Microbiology 101, 143-146. Go to original source... Go to PubMed...
  2. Anadon A, Martinez-Larranaga MR, Diaz MJ, FernandezCruz MI, Martinez MA, Frejo MT, Martinez M, Iturbe J, Tafur M (1999): Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. American Journal of Veterinary Research 60, 1377-1382. Go to original source...
  3. Biberstein EL (1990): Our understanding of the Pasteurellaceae. Canadian Journal of Veterinary Research 54, 78-82.
  4. Burch DGS (2010): Antimicrobial concentrations in plasma and lung and their relationships to bacterial respiratory infections. The Pig Journal 63, 34-49.
  5. Cai X, Chen H, Blackall PJ, Yin Z, Wang L, Liu Z, Jin M (2005): Serological characterization of Haemophilus parasuis isolates from China. Veterinary Microbiology 111, 231-236. Go to original source... Go to PubMed...
  6. Carbone M, Pennisi MG, Masucci M, De Sarro A, Giannone M, Fera MT (2001): Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates. Veterinary Microbiology 81, 79-84. Go to original source... Go to PubMed...
  7. Cester CC, Toutain PL (1997): A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. Journal of Pharmaceutical Sciences 86, 1148-1155. Go to original source... Go to PubMed...
  8. CLSI - Clinical and Laboratory Standards Institute (2013a): Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - Fourth Edition. CLSI document Vet 01-A4. Clinical and Laboratory Standards Institute, Wayne. 73 pp.
  9. CLSI - Clinical and Laboratory Standards Institute (2013b): Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Second Informational Supplement. CLSI document Vet 01-S2. Clinical and Laboratory Standards Institute, Wayne. 63 pp.
  10. Craig WA (1993): Post-antibiotic effects in experimental infection models: relationship to in vitro phenomena and to treatment of infections in man. Journal of Antimicrobials and Chemotherapy 31, 149-158. Go to original source... Go to PubMed...
  11. Craig WA, Gudmundsson S (1996): The postantibiotic effect. In: Lorian V (ed.): Antibiotics in Laboratory Medicine. 4th edn. The Williams & Wilkins Co. 296-329.
  12. Craig WA, Vogelman B (1986): The postantibiotic effect. Annals of Internal Medicine 106, 900-902. Go to original source... Go to PubMed...
  13. de Jong A, Thomas V, Simjee S, Moyaert H, El Garch F, Maher K, Morrissey I, Butty P, Klein U, Marion H, Rigaut D, Valle M (2014): Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Veterinary Microbiology 172, 202-205. Go to original source... Go to PubMed...
  14. De la Fuente AJ, Tucker AW, Navas J, Blanco M, Morfia SJ, Gutierrez-Martin CB (2007): Antimicrobial susceptibility patterns of Haemophilus parasuis from pigs in the United Kingdom and Spain. Veterinary Microbiology 120, 184-191. Go to original source... Go to PubMed...
  15. El Garch F, de Jong A, Simjee S, Moyaert H, Klein U, Ludwig C, Marion H, Haag-Diergarten S, Richard-Mazet A, Thomas V, Siegwart E (2016): Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results. Veterinary Microbiology 194, 11-22. Go to original source... Go to PubMed...
  16. El Garch F, Kroemer S, Galland D, Morrissey I, Woehrle F (2017): Survey of susceptibility to marbofloxacin in bacteria isolated from diseased pigs in Europe. Veterinary Record 180, doi: 10.1136/vr.103954. Go to original source... Go to PubMed...
  17. Garcia Ovando H, Gorla N, Luders C, Poloni G, Errecalde G, Prieto G, Puelles I (1999): Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in chickens. Journal of Veterinary Pharmacology and Therapeutics 22, 209-212. Go to original source... Go to PubMed...
  18. Gerber AU, Craig WA (1981): Growth kinetics of respiratory pathogens after short exposure to ampicillin and erythromycin in vivo. Journal of Antimicrobial Agents and Chemotherapy 8, 81-91. Go to original source... Go to PubMed...
  19. Gould IM, Milne K, Jason C (1991): Post antibiotic effect of co-amoxyclav. In: 5th European Congress on Clinical Microbiology and Infectious Disease. European Society of Clinical Microbiology and Infection Diseases. September 9.-11. 1991. Abstract 1360.
  20. Hao H, Pan H, Ahmad I, Cheng G, Wang Y, Dai M, Tao Y, Chen D, Peng D, Liu Z, Huang L, Yuan Z (2013): Susceptibility breakpoint for enrofloxacin against swine Salmonella spp. Journal of Clinical Microbiology 51, 3070-3072. Go to original source... Go to PubMed...
  21. Harada K, Shimizu T, Kataoka Y, Takahashi T (2012): Postantibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs. Acta Veterinaria Scandinavica 54, 744-754. Go to original source... Go to PubMed...
  22. Hossain MA, Park HC, Jeong K, Jang YH, Kim DG, Kang J, Lee KJ (2017): Pharmacokinetic and pharmacodynamic evaluation of marbofloxacin in pig against Korean local isolates of Actinobacillus pleuropneumoniae. BioMed Research International 2017, doi: 10.1155/2017/2469826. Go to original source... Go to PubMed...
  23. Idowu OR, Peggins JO, Cullison R, Bredow J (2010): Comparative pharmatokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin. Research in Veterinary Science 89, 230-235. Go to original source... Go to PubMed...
  24. Licata L, Smith CE, Goldschmidt RM, Barrett JF, Frosco M (1997): Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 950-955. Go to original source... Go to PubMed...
  25. Messenger KM, Papich MG, Blikslager AT (2012): Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs. Journal of Veterinary Pharmacology and Therapeutics 35, 452-459. Go to original source... Go to PubMed...
  26. Nedbalcova K, Kucerova Z (2013): Antimicrobial susceptibility of Pasteurella multocida and Haemophilus parasuis isolates associated with porcine pneumonia. Acta Veterinaria Brno 82, 3-7. Go to original source...
  27. Nedbalcova K, Satran P, Jaglic Z, Ondriasova R, Kucerova Z (2006): Haemophilus parasuis and Glasser's disease in pigs: a review. Veterinarni Medicina 51, 168-179. Go to original source...
  28. Nedbalcova K, Nechvatalova K, Pokludova L, Bures J, Kucerova Z, Koutecka L, Hera A (2014): Resistance to selected beta-lactam antibiotics. Veterinary Microbiology 171, 328-336. Go to original source... Go to PubMed...
  29. Nedbalcova K, Zouharova M, Sperling D (2017): The determination of minimum inhibitory concentrations of selected antimicrobials for porcine Haemophilus parasuis isolates from the Czech Republic. Acta Veterinaria Brno 86, 175-181. Go to original source...
  30. Nouws JFM, Mevius DJ, Vree TB, Baars AM, Laurensen J (1988): Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Veterinary Quarterly 10, 156-163. Go to original source... Go to PubMed...
  31. Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK (2002): Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid. The Veterinary Journal 163, 85-93. Go to original source... Go to PubMed...
  32. Rescott DL, Nix DE, Holden P, Schentag JJ (1988): Comparison of two methods for determining in vitro postantibiotic effect of three antibiotics on Escherichia coli. Antimicrobial Agents and Chemotherapy 32, 450-453. Go to original source... Go to PubMed...
  33. Sweeney MT, Lindeman C, Johansen L, Mullins L, Murray R, Senn MK, Bade D, Maqchin C, Kotarski SF, Tiwari R (2017): Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica isolated from pigs in the United States and Canada, 2011 to 2015. Journal of Swine Health and Production 25, 106-120. Go to original source...
  34. Tanigawa M, Sawada T (2002): Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae. Journal of Veterinary Medicine Series B 49, 513-518. Go to original source... Go to PubMed...
  35. Thorburn CE, Moleswoth SJ (1992): The post β-lactamase inhibitor effect (PLIE): a novel aspect of the activity of clavulanic acid in antibacterial tests. In: 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. October 11.-14. 1992. Abstract 540.
  36. Thorburn CE, Moleswoth SJ, Sutherland J, Rittenhouse S (1996): Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate. Antimicrobial Agents and Chemotherapy 40, 2796-2801. Go to original source... Go to PubMed...
  37. Trouchon T, Lefebvre S (2016): A review of enrofloxacin for veterinary use. Open Journal of Veterinary Medicine 6, 40-58. Go to original source...
  38. Wang J, Hao H, Huang L, Liu Z, Chen D, Yuan Z (2016): Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli. Frontiers in Microbiology 7, doi: 10.3389/fmicb.2016.00036. Go to original source... Go to PubMed...
  39. Wetzstein HG (1994): The in vitro postantibiotic effect of enrofloxacin. Proceedings of the 18th World Buiatrics Congress, 615-618.
  40. Zhao DH, Yu Y, Zhou YF, Shi W, Deng H, Liu YH (2014): Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens. Letters in Applied Microbiology 58, 150-155. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.